Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective iGluR5 receptor antagonists for the treatment of migraine

Selective iGluR5 receptor antagonists for the treatment of migraine

US Patent 6566370 · Granted May 20, 2003

Estimated economic value: $207,941,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chronic nightly dosing of lasmiditan for migraine prevention2024
6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA2016
4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonist2015
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor ant2012
Serotonin and norepinephrine reuptake inhibitor2012
Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists2011
5-HT7 receptor antagonists2011
Pyrrole and pyrazole derivatives as potentiators of glutamate receptors2009
(Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl a2009
Excitatory amino acid receptor antagonists2009
Enantiomers of selected fused heterocyclics and uses thereof2009
3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin 2008